GFPT1 has been shown to promote breast cancer progression and immune escape through O-glycosylation-modified PD-L1, highlighting its potential role in tumor immune evasion mechanism (Tang et al., 2024). This evidence concerns the gene GFPT1 and breast carcinoma.